However, to realize true precision surgery, precise surgical instruments should be complemented with precise target definition by molecular detection (i.e., miniaturized detection, steerability, augmented data display) [21], innovations that are supported by the advances made in radiochemistry (i.e., novel (tumor-targeted) radiopharmaceuticals, e.g., 99mTc-PSMA I&S [40], 99mTc-folate [41], 99mTc-FAPI-34 [42], 99mTc- or 111In-labeled somatostatin analogs [43]). Here, FOLH1 is linked to neoplasm.